MicroRNA-200a suppresses migration and invasion and enhances the radiosensitivity of NSCLC cells by inhibiting the HGF/c-Met signaling pathway

被引:31
作者
Du, Menghua [1 ,3 ]
Wang, Jin [1 ]
Chen, Huan [1 ]
Wang, Shouli [2 ]
Chen, Liesong [1 ]
Xu, Yichang [2 ]
Su, Fengtao [3 ]
Lu, Xueguan [1 ,4 ]
机构
[1] Soochow Univ, Affiliated Hosp 2, Dept Oncol & Radiotherapy, Suzhou 215123, Jiangsu, Peoples R China
[2] Soochow Univ, Sch Biol & Basic Med Sci, Dept Pathol, Suzhou 215123, Jiangsu, Peoples R China
[3] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Canc Inst, 270 Dongan Rd, Shanghai 200032, Peoples R China
[4] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, 270 Dongan Rd, Shanghai 200032, Peoples R China
关键词
lung cancer; miRNA-200a; hepatocyte growth factor; c-met signal pathway; radiosensitivity; HEPATOCYTE GROWTH-FACTOR; LUNG-CANCER; ELEVATED EXPRESSION; CMET; RADIORESISTANCE; OVEREXPRESSION; DYSREGULATION; SENSITIVITY; ACTIVATION; RESISTANCE;
D O I
10.3892/or.2018.6925
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocyte growth factor (HGF), an activator of the c-Met signaling pathway, is involved in tumor invasiveness, metastasis and radiotherapy resistance. In the present study, a novel HGF regulatory pathway in lung cancer involving microRNAs (miRNAs/miR) is described. Immunohistochemical staining and western blot analyses demonstrated that HGF was upregulated and associated with miR-200a downregulation in non-small cell lung cancer (NSCLC) samples compared with normal lung tissues. The association between HGF and miR-200a was associated with the degree of tumor malignancy and cell migration and invasion. miR-200a negatively regulated HGF expression by targeting the 3-untranslated region of the HGF mRNA. miR-200a overexpression induced HGF downregulation, decreased NSCLC cell migration and invasion, promoted apoptosis, and decreased cell survival in A549 and H1299 cells in response to ionizing radiation. The present results revealed a previously uncharacterized role of miRNA-200a in regulating tumor malignancy and radiosensitivity by suppressing HGF expression, a key factor in the HGF/c-Met pathway.
引用
收藏
页码:1497 / 1508
页数:12
相关论文
共 51 条
  • [1] [Anonymous], CELL BIOCHEM BIOPHYS
  • [2] [Anonymous], CLIN CANC RES
  • [3] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [4] Modulation of c-Met signaling and cellular sensitivity to radiation Potential Implications for Therapy
    Bhardwaj, Vikas
    Cascone, Tina
    Cortez, Maria Angelica
    Amini, Arya
    Evans, Jaden
    Komaki, Ritsuko U.
    Heymach, John V.
    Welsh, James W.
    [J]. CANCER, 2013, 119 (10) : 1768 - 1775
  • [5] Registered report: Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
    Blum, David
    LaBarge, Samuel
    [J]. ELIFE, 2014, 3
  • [6] Targeting the Hepatocyte Growth Factor-cMET Axis in Cancer Therapy
    Blumenschein, George R., Jr.
    Mills, Gordon B.
    Gonzalez-Angulo, Ana M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3287 - 3296
  • [7] Cancer Statistics in China, 2015
    Chen, Wanqing
    Zheng, Rongshou
    Baade, Peter D.
    Zhang, Siwei
    Zeng, Hongmei
    Bray, Freddie
    Jemal, Ahmedin
    Yu, Xue Qin
    He, Jie
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) : 115 - 132
  • [8] MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer
    Chen, Yongbing
    Du, Menghua
    Wang, Jin
    Xing, Pengfei
    Zhang, Yongsheng
    Li, Feng
    Lu, Xueguan
    [J]. ONCOTARGET, 2016, 7 (30) : 48432 - 48442
  • [9] Cherni I, 2011, FUTURE ONCOL, V7, P1045, DOI [10.2217/fon.11.74, 10.2217/FON.11.74]
  • [10] Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer
    Cortez, Maria Angelica
    Valdecanas, David
    Zhang, Xiaochun
    Zhan, Yanai
    Bhardwaj, Vikas
    Calin, George A.
    Komaki, Ritsuko
    Giri, Dipak K.
    Quini, Caio C.
    Wolfe, Tatiana
    Peltier, Heidi J.
    Bader, Andreas G.
    Heymach, John V.
    Meyn, Raymond E.
    Welsh, James W.
    [J]. MOLECULAR THERAPY, 2014, 22 (08) : 1494 - 1503